According to Eterna Therapeutics's latest financial reports the company's current EPS (TTM) is -65,43ย โฌ. In 2022 the company made an earnings per share (EPS) of -107,35ย โฌ an increase over its 2021 EPS that were of -709,23ย โฌ.